INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP

Clinical trial NCT06144840 · COMPLETED

Trial details

NCT number: NCT06144840
Sponsor: Tanabe Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Erythropoietic Protoporphyria (EPP)X-Linked Protoporphyria (XLP)

Start date: 2023-12-11
Primary completion: 2026-04-14
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.